IDEXX Laboratories Inc

NASDAQ IDXX

Data sourced from

and

Download Data

IDEXX Laboratories Inc Accounts Payable Turnover Ratio 5 year CAGR for the year ending December 31, 2023: 0.78%

IDEXX Laboratories Inc Accounts Payable Turnover Ratio 5 year CAGR is 0.78% for the year ending December 31, 2023, a 1.26% change year over year. The accounts payable turnover ratio measures the number of times a company pays off its accounts payable during a specific period. It is calculated by dividing the company's revenue by its accounts payable. This ratio indicates how efficiently a company manages its outstanding payments to suppliers and vendors. A higher turnover ratio suggests that the company is paying off its obligations quickly, while a lower ratio may indicate a slower payment process or potential liquidity issues. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.

IDEXX Laboratories Inc Accounts Payable Turnover Ratio for the year ending December 31, 2022 was 30.55, a 10.35% change year over year.
IDEXX Laboratories Inc Accounts Payable Turnover Ratio for the year ending December 31, 2021 was 27.69, a -23.74% change year over year.
IDEXX Laboratories Inc Accounts Payable Turnover Ratio for the year ending December 31, 2020 was 36.30, a 8.85% change year over year.
IDEXX Laboratories Inc Accounts Payable Turnover Ratio for the year ending December 31, 2019 was 33.35, a 4.78% change year over year.

NASDAQ: IDXX

IDEXX Laboratories Inc

CEO	Mr. Jonathan J. Mazelsky
IPO Date	June 21, 1991
Location	United States
Headquarters	One IDEXX Drive, Westbrook, ME, United States, 04092
Employees	11,000
Sector	Healthcare
Industry	Diagnostics & research

Description

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Key trends